WANG LAW FIRM Let a former scientist handle your immigration affairs

 
Home    
 
 
Success Stories        
 
Contact Us      
 
 


                                Sample Cases (Aliens of extraordinary ability)

EB1A-291: The petitioner/beneficiary was a biomedical scientist (cancer researchand worked at a US private research hospital. He earned his Ph.D. in the United States and published nine journal research articlesThese publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).

EB1A-290: The petitioner/beneficiary was a chemical and materials scientist (biotechnologyand worked at a US private research institute. He earned his Ph.D. in the United States and published over ten journal research articlesThese publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).

EB1A-289: The petitioner/beneficiary was a biomedical scientist (cell reprogramming, genomicsand worked at a US private research institute. He earned his Ph.D. in China and published six journal research articlesThese publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).

EB1A-288: The petitioner/beneficiary was a biomedical scientist (cancer researchand worked at a US public university. He earned his Ph.D. in the United States and published over twenty journal research articlesThese publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-287: The petitioner/beneficiary was a chemical scientist (analytical chemistryand worked at a US biopharmaceutical company. She earned her Ph.D. in the United States and published about ten journal research articlesThese publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-286: The petitioner/beneficiary was a biomedical scientist (eye diseaseand worked at a US private university. She earned her Ph.D. in China and published over ten journal research articlesThese publications were moderately cited by others. The petition was filed in 2018 and approved three months later (After RFE).

EB1A-285: The petitioner/beneficiary was a biomedical scientist (hypertension, gut microbiota and worked at a US public university. He earned his Ph.D. in the United States and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-284: The petitioner/beneficiary was a biomedical scientist (human genetics, gene mutationsand worked at a US research hospital. He earned his Ph.D. in China and published twenty journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-283: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, protein structureand worked at a US medical school. He earned his Ph.D. in the United States and published six journal research articles. These publications were widely cited by others. The petition was filed in 2017 and approved one year later (after RFE).

EB1A-282: The petitioner/beneficiary was a biomedical scientist (neuroscience, pain researchand worked at a US private university. She earned her Ph.D. in China and published ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-281: The petitioner/beneficiary was a pharmaceutical scientist (pharmacology, population pharmacokineticsand worked at a major pharmaceutical company. She received undergraduate education in China and earned her Ph.D. in the United States. The petitioner published 13 journal research articles. Some publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-280: The petitioner/beneficiary was a biomedical scientist (brain disease, neuroscienceand worked at a US medical school and private hospital. He received his Ph.D. in the United States and published seven journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-279: The petitioner/beneficiary was a computer scientist (bioinformatics, computational biologyand worked at a US medical school. He earned his Ph.D. in Computer Science in China and received postdoctoral training in the United States. The petitioner co-authored and published some research articles and book chapters in Chinese and English. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-278: The petitioner/beneficiary was a scientist in biomedical engineering (single cell mechanobiology, tissue engineeringand worked at a US public university. She received her Ph.D. in the United States and published over ten journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-277: The petitioner/beneficiary was a medical scientist (stem cell therapyand worked at a US medical school. She received her Ph.D. in China and published eight journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-276: The petitioner/beneficiary was a biomedical scientist (insect immunology, immunologyand worked at a US medical school. She received her Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved four months later (after RFE).

EB1A-275: The petitioner/beneficiary was a biomedical scientist (autophagyand worked at a US public university. She received her Ph.D. in the United States and published over 10 journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-274: The petitioner/beneficiary was a biological scientist (neuroscienceand worked at a US private university. He received Ph.D. in the United States and published over several journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved one week later (No RFE).
EB1A-278: The petitioner/beneficiary was a scientist in biomedical engineering (single cell mechanobiology, tissue engineeringand worked at a US public university. She received her Ph.D. in the United States and published over 10 research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).

EB1A-273: The petitioner/beneficiary was a chemical scientist (organic chemistryand worked at a US medical school. He received Ph.D. in China and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-272: The petitioner/beneficiary was a medical scientist (stem cell, biomedical engineeringand worked at a US medical school. He received Ph.D. in China and published about 10 research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-271: The petitioner/beneficiary was a medical scientist (HCV, cell reprogrammingand worked at a US medical school. She received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-270: The petitioner/beneficiary was a medical scientist (neuroscience, neurodegenerative diseaseand worked at a US medical school. He received Ph.D. in China and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-269: The petitioner/beneficiary was a biological scientist (autophagyand worked at a US public university. He received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (after RFE).

EB1A-268: The petitioner/beneficiary was a medical scientist (stem cells, cancer, epigeneticsand worked at a US medical school. He received Ph.D. in China and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-267: The petitioner/beneficiary was a medical scientist (human medical genetics, RNA biologyand worked at a US medical school. He received Ph.D. in China and published over 50 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-266: The petitioner/beneficiary was a chemical scientist (natural products, drug development, biomaterialsand worked at a US medical school. He received Ph.D. in Hong Kong and published over 10 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-265: The petitioner/beneficiary was a mathematical scientist (computational mathematicsand worked at an Associate Professor at a US public university. He received Ph.D. in the United States and published over 50 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-264: The petitioner/beneficiary was a chemical scientist (analytical chemistry, proteomics, mass spectrometry, etc.and worked at a US private university. He received Ph.D. in China and published over 30 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-263: The petitioner/beneficiary was a biomedical scientist (obesity, diabetes, adipose tissue, stress response, nutritional scienceand worked at a US medical school. He received Ph.D. in China and published about twenty research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-262: The petitioner/beneficiary was a neuroscientist (memory and learning, sexual behaviorand worked at a US medical school. He received Ph.D. in Austria and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-261: The petitioner/beneficiary was a materials scientist (batteryand worked at a US national laboratory. He received Ph.D. in the United States and published nine research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-260: The petitioner/beneficiary was a biomedical scientist (maternal diabetes, cardiovascular diseaseand worked at a US public university. She received Ph.D. in China and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-259: The petitioner/beneficiary was a biophysicist and biomedical scientist (biophysics, biomedical engineering, etc.and worked at a US public university. He received M.S. in China and Ph.D. in the United States and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-258: The petitioner/beneficiary was a biomaterials scientist (biomedical and mechanical engineeringand worked at a US public university. He received Ph.D. in Canada and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-257: The petitioner/beneficiary was a biochemist (traditional Chinese medicine, cardiovascular diseaseand worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-256: The petitioner/beneficiary was a biomedical scientist (developmental biology, stem cellsand worked at a US public university. She received Ph.D. in China and published seventeen research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-255: The petitioner/beneficiary was a biomedical scientist (skin disease, melanoma, prostate cancerand worked at a US public university. He received Ph.D. in Sweden and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-254: The petitioner/beneficiary was a biomedical scientist (cancer researchand worked at a US public university. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-253: The petitioner/beneficiary was a biomedical scientist (RNA biology, X chromosome inactivationand worked at a US medical school. He received Ph.D. in the United States and published eight research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-252: The petitioner/beneficiary was a biomedical scientist (cancer researchand worked at a US medical school. He received Ph.D. in China and published over twenty research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).

EB1A-251: The petitioner/beneficiary was a biomedical scientist (genomics, bioinformatics, stem cellsand worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).